SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services such as lead generation and content for other financial services institutions. The company was founded in 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi is trending as investors eagerly anticipate earnings, with many hoping for a strong report to push the stock higher. Community discussions revolve around potential S&P 500 inclusion and the impact of future interest rate cuts on the fintech company. Bullish sentiment is high, with some comparing SoFi to other disruptive tech stocks.

Galaxy Digital, Inc. engages in digital assets and data center infrastructure, delivering solutions that accelerate progress in finance and artificial intelligence. It operates through the following segments: Digital Assets and Data Centers. The digital assets segment offers institutional access to trading, advisory, asset management, staking, self-custody, and tokenization technology. The Data Centers segment competes with a range of infrastructure providers that are building or repurposing facilities to support the rapidly growing demand for AI and compute-intensive workloads. The company was founded by Michael Novogratz in 2018 and is headquartered in New York, NY.

Galaxy Digital Inc. - Ordinary Shares - Class A

GLXY is trending due to a recent $1B convertible note offering, leading to community debate on whether it's a strategic move for data center expansion or a dilution risk.  Despite strong earnings and expansion plans, investors are wary, drawing comparisons to other crypto firms and questioning the timing of the offering. Discussions also involve the company's potential ERCOT approval for its Texas data center campus.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group (UNH) is trending as investors discuss upcoming earnings and potential market reactions. Community members are actively debating whether UNH will beat expectations, with some expressing nervousness about holding large positions through the release, while others analyze options strategies to capitalize on potential volatility. Broader discussions include the health sector's overall outlook and the impact of external factors like interest rate decisions.

Pump.fun

$PUMP is gaining traction within the crypto community, particularly on Solana ($SOL), with discussions centered around the 'We're All Gonna Make It' ($WAGMI) ethos. Community members highlight the token's resilience and potential within the meme coin space, emphasizing its long-term vision and strong community backing. The focus remains on community, narratives, and a belief in the project's future.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is trending as investors assess its potential following a JPMorgan price target hike and anticipation builds for upcoming earnings, with community chatter focusing on the company's AI prospects and sustained uptrend. Discussions also involve potential integrations with SpaceX's Starlink and speculation around a possible donation to a Trump White House project. Technical analysis suggests a buying opportunity and further upside potential, while some caution about valuation.

ETHZilla Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded by Marc Feldmann, Lawrence J. Steinman, and Jonathan B. Rothbard on September 7, 2016 and is headquartered in Palm Beach, FL.

ETHZilla Corp

ETHZilla Corporation

ETHZ is trending due to discussions around its stock repurchase program and the potential impact of Ethereum's price movements on the company's value. Community members are debating the company's strategy of selling ETH to buy back shares, with some seeing it as a smart move and others questioning its long-term viability. Broader market factors, including potential agreements between the U.S. and China, and the performance of other crypto-related stocks, are also influencing the conversation.

Hedera is a decentralized public network where developers can build secure, fair applications with near real-time consensus. The platform is owned and governed by a council of global innovators including Avery Dennison, Boeing, Deutsche Telekom, DLA Piper, FIS (WorldPay), Google, IBM, LG Electronics, Magalu, Nomura, Swirlds, Tata Communications, University College London (UCL), Wipro, and Zain Group.   The Hedera Consensus Service (HCS) acts as a trust layer for any application or permissioned network and allows for the creation of an immutable and verifiable log of messages. Application messages are submitted to the Hedera network for consensus, given a trusted timestamp, and fairly ordered. Use HCS to track assets across a supply chain, create auditable logs of events in an advertising platform, or even use it as a decentralized ordering service.

Hedera Hashgraph

Hedera Hashgraph is trending as the community anticipates a potential ETF listing, sparking excitement about institutional investment and increased liquidity. Community members are discussing potential price appreciation and real-world use cases. Some investors express frustration with the token's historical performance, while others remain optimistic about its long-term potential amid regulatory developments.

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics ($NTLA) is trending due to a trial pause after a patient experienced liver enzyme elevations, sparking a sharp decline in the stock price. The community is debating the severity of the event, the potential impact on Intellia's pipeline, and whether the sell-off is an overreaction or a buying opportunity.  Some investors are optimistic about a potential rebound, while others express concerns about the safety profile of the gene-editing therapy.

United Parcel Service, Inc. is a package delivery company, which engages in the provision of global supply chain management solutions. It operates through the following segments: U.S. Domestic Package, International Package, and Supply Chain Solutions. The U.S. Domestic Package segment includes time-definite delivery of letters, documents, and packages. The International Package segment focuses on delivery and shipments in Europe, Asia, the Indian sub-continent, the Middle East, Africa, Canada, and Latin America. The Supply Chain Solutions is involved in forwarding, logistics, Coyote, Marken, and UPS Mail Innovations. The company was founded by James E. Casey and Claude Ryan on August 28, 1907 and is headquartered in Atlanta, GA.

United Parcel Service, Inc. - Ordinary Shares - Class B

United Parcel Service, Inc.

UPS is trending as investors weigh the potential impact of restructuring efforts and upcoming earnings, with community members discussing dividend sustainability and volume concerns. Some traders express optimism based on after-hours activity and potential for a holiday season boost, while others fear a dividend cut and continued struggles with profitability. The stock's valuation and potential takeover scenarios are also circulating as talking points.

Rambus, Inc. engages in the provision of cutting-edge semiconductor and Internet Protocol products, spanning memory and interfaces to security, smart sensors and lighting. Its products include Memory Interface Chips, Interface IP, and Security IP. The company was founded by P. Michael Farmwald and Mark A. Horowitz in March 1990 and is headquartered in Sunnyvale, CA.

Rambus Inc.

Rambus is trending due to concerns around its latest earnings report, which revealed a revenue miss despite beating EPS estimates. The community is focused on the company's guidance and the impact of higher income tax expenses on margins, while some believe Rambus's connection to Micron Technology ($MU) still makes it a worthwhile play in the memory market.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Orthofix to Participate in Upcoming Investor Conferences

Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that Massimo Calafiore, President and Chief Executive Officer, and Julie Andrews, Chief Financial...

Orthofix to Report Third Quarter 2025 Financial Results

Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its third quarter 2025 financial results on Tuesday, November 4, 2025, before...

FMS vs. OFIX: Which Stock Is the Better Value Option?

ZBH Receives PMDA Approval in Japan for iTaperloc Complete and iG7 

Zimmer Biomet wins early PMDA approval in Japan for its iTaperloc Complete and iG7 Hip System with Iodine Technology.

FMS vs. OFIX: Which Stock Should Value Investors Buy Now?

Orthofix (OFIX) Q2 Earnings and Revenues Beat Estimates

Orthofix (OFIX) delivered earnings and revenue surprises of +225.00% and +3.51%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Idexx Laboratories (IDXX) Tops Q2 Earnings and Revenue Estimates

Idexx (IDXX) delivered earnings and revenue surprises of +9.67% and +4.01%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Orthofix Reports Fourth Quarter and Full-Year 2024 Results and Provides 2025 Financial Guidance

Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the fourth quarter and full-year ended December 31, 2024, and provided...

Orthofix to Participate in the Canaccord Genuity 2025 Musculoskeletal Conference

Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that the Company will participate in the Canaccord Genuity 2025 Musculoskeletal Conference in San...

Orthofix to Report Fourth Quarter and Full-Year 2024 Financial Results

Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its fourth quarter and full-year 2024 financial results on Tuesday, February 25...

Orthofix Medical, Inc. engages in the provision of medical devices. It operates through the following business segments: Global Spine and Global Extremities. The Global Spine reporting segment offers three primary product categories: Bone Growth Therapies, Spinal Implants, and Biologics. The Bone Growth Therapies product category manufactures, distributes, and provides support services of bone growth stimulator devices that enhance bone fusion. The Spinal Implants product category designs, develops, and markets a broad portfolio of motion preservation and fixation implant products used in surgical procedures of the spine. The Biologics product category provides a portfolio of regenerative products and tissue forms that allow physicians to treat a variety of spinal and orthopedic conditions. The Global Extremities reporting segment offers products and solutions that allow physicians to successfully treat a variety of orthopedic conditions unrelated to the spine. The company was founded on October 19, 1987 and is headquartered in Lewisville, TX.

Orthofix Medical Inc

Will Alphabet ($GOOGL) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Alphabet Inc Class A

) beat quarterly earnings? 
 
*Powered by Polymarket

Current Price	$16.08
Prev Close	$15.97
Open	$15.97
Dividend Yield	0.00%
50-Day Moving Average	$14.79
Beta	1.16
Avg. Volume	338,699.48
PE Ratio	-5.06

52-Week High	$20.73
52-Week Low	$10.24
Market Capitalization	$635.07M
EPS (Annual)	-$3.30
Price to Book	1.39
Revenue Per Employee	$494,734.53
Enterprise Value/EBITDA	N/A

OFIX
Orthofix Medical Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest OFIX News

OFIXOrthofix Medical Inc